Source: Eur Respir J 2014; 43: 325-328



Rating:

Share or cite this content

Citations should be made in the following way:
Voelkel Norbert F., Humbert Marc. Translational research in pulmonary hypertension: challenge and opportunity. Eur Respir J 2014; 43: 325-328

Member's Comments

No comment yet.

Related content which might interest you: Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018 Year: 2019 Challenges in pulmonary hypertension: managing the unexpected Source: Eur Respir Rev 2015; 24: 674-681 Year: 2015 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Pulmonary hypertension: basic concepts and practical management Source: Eur Respir J 2008; 31: 236-237 Year: 2008 Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017 Year: 2017 Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives Source: Eur Respir Rev 2016; 25: 135-140 Year: 2016 A regional nurse study day using small group tutorials- A successful novel approach to publicising pulmonary hypertension Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals Year: 2013 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Contemporary issues in pulmonary hypertension Source: Eur Respir Rev 2010 19: 266-271 Year: 2010 The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress Source: Eur Respir J 2015; 46: 879-882 Year: 2015 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 The importance of patient perspectives in pulmonary hypertension Source: Eur Respir J, 53 (1) 1801919; 10.1183/13993003.01919-2018 Year: 2019 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Programme SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Programme SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015 Reading list SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016